Cargando…

The adverse reactions to vaccines practice parameter 10 years on—what have we learned?

OBJECTIVE: To provide updated information on the evaluation and management of adverse reactions to vaccines. DATA SOURCES: PubMed (MEDLINE) search since publication of a practice parameter in 2012. STUDY SELECTIONS: Original articles and guidelines on adverse reactions to vaccines, including vaccine...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kelso, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801260/ https://www.ncbi.nlm.nih.gov/pubmed/35101646 http://dx.doi.org/10.1016/j.anai.2022.01.026

Ejemplares similares

The adverse reactions to vaccines practice parameter 10 years on—what have we learned?
por: Wolfson, Anna R.
Publicado: (2022)

What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later
por: Copaescu, Ana M., et al.
Publicado: (2022)

10 Years of belimumab experience: What have we learnt?
por: Levy, Roger A, et al.
Publicado: (2021)

Risk factors for immune-related adverse events: what have we learned and what lies ahead?
por: Liu, Xiaoyan, et al.
Publicado: (2021)

What Have We Learned in 30 Years of Investigations on Bari Transposons?
por: Palazzo, Antonio, et al.
Publicado: (2022)

Multiorgan failure in malaria: what we have learned over the past 10 years
por: Zeippen, B, et al.
Publicado: (2001)

Review and publication of protocol submissions to Trials – what have we learned in 10 years?
por: Li, Tianjing, et al.
Publicado: (2016)

Thirty years of endoscopic sinus surgery: What have we learned?
por: Tajudeen, Bobby A., et al.
Publicado: (2017)

Phage Therapy: What Have We Learned?
por: Górski, Andrzej, et al.
Publicado: (2018)

30 years of HIV: what have we learned?
por: Gazzard, Brian
Publicado: (2014)

Cutaneous manifestation of COVID-19: What have we learned an year into the pandemic?
por: Sodeifian, F., et al.
Publicado: (2022)

What have we learned?
por: Rodgers, Peter, et al.
Publicado: (2021)

Endometriosis and Reproduction: What We Have Learned
por: Garcia-Fernandez, Jaime, et al.
Publicado: (2020)

Bacteriophages and antibiotic interactions in clinical practice: what we have learned so far
por: Łusiak-Szelachowska, Marzanna, et al.
Publicado: (2022)

Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?
por: Godoy, Luani Rezende, et al.
Publicado: (2022)

Orthopaedic infections: what have we learned?
por: Lee, Christopher, et al.
Publicado: (2023)

Genetics of rheumatoid arthritis: what have we learned?
por: Bax, Marieke, et al.
Publicado: (2011)

Five decades of Fontan palliation: What have we learned? What should we expect?
por: Hassan, Adil, et al.
Publicado: (2023)

The next 10 years for tuberculosis vaccines: do we have the right plans in place?
por: Meyer, Joel, et al.
Publicado: (2013)

Mathematics Anxiety: What Have We Learned in 60 Years?
por: Dowker, Ann, et al.
Publicado: (2016)

Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)

Robotic Prostatectomy: What We Have Learned and Where We Are Going
por: Lee, David I.
Publicado: (2009)

Toxoplasmosis vaccines: what we have and where to go?
por: Zhang, Yizhuo, et al.
Publicado: (2022)

Biomechanics and neural control of movement, 20 years later: what have we learned and what has changed?
por: Nordin, Andrew D., et al.
Publicado: (2017)

School Asthma Care During COVID-19: What We Have Learned and What We Are Learning
por: Abrams, Elissa M., et al.
Publicado: (2022)

Residual macrovascular risk in 2013: what have we learned?
por: Fruchart, Jean-Charles, et al.
Publicado: (2014)

The multitubulin hypothesis revisited: what have we learned?
Publicado: (1987)

Drosophila Models of Tauopathies: What Have We Learned?
por: Gistelinck, Marc, et al.
Publicado: (2012)

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

PTH Assays: Understanding What We Have and Forecasting What We Will Have
por: Vieira, Jose Gilberto H.
Publicado: (2012)

GOAL: What Have We Learned?
por: Leek, Timothy K Vander
Publicado: (2005)

What have we learned on mesons?
por: Moebes, J P
Publicado: (1972)

SARS: What have we learned?
Publicado: (2003)

What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions
por: Awaya, Toru, et al.
Publicado: (2022)

Sixteen Years since the Convention on the Rights of Persons with Disabilities: What Have We Learned since Then?
por: Martínez-Medina, Andrés, et al.
Publicado: (2022)

Medication-related adverse events in health care—what have we learned? A narrative overview of the current knowledge
por: Laatikainen, O., et al.
Publicado: (2021)

What have we learned from brucellosis in the mouse model?
por: Grilló, María-Jesús, et al.
Publicado: (2012)

In the aftermath of the Fusarium keratitis outbreak: What have we learned?
por: Epstein, Arthur B
Publicado: (2007)

Cerebral cortex expansion and folding: what have we learned?
por: Fernández, Virginia, et al.
Publicado: (2016)

Two decades with omalizumab: what we still have to learn
por: Incorvaia, Cristoforo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5kpe0b8edmfpbd664od5q6a5ss